Analyst Ratings for Actus Medical (AFIB) [Neutrals]

AFIB Rating Summary

AFIB Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AFIB
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $24.50 (+106.2%) * Over Last 12-Mos
Rating Score: 2 / 10   Percentile Rank: 14%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/19/2021 William Blair Ryan Daniels Downgrade Market Perform
(Outperform)
N/A
(N/A)
19.06
(11.88)
-37.67% Details
3/19/2021 JPMorgan Robbie Marcus Downgrade Neutral
(Overweight)
19.00
(39.00)
19.06
(11.88)
-37.67% Details